BECTON, DICKINSON AND COMPANY (BDX) FY2025 Annual P&L / Income Statement
2024-10-01 to 2025-09-30
Revenue by Business Segment
2024-10-01 to 2025-09-30
Swipe to see the full flow
Chart details
BECTON, DICKINSON AND COMPANY (BDX) FY2025 Annual P&L / Income Statement
Income statement for 2024-10-01 through 2025-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Revenues
- 21,840,000,000 US dollars
- Cost of products sold
- 11,915,000,000 US dollars
- Gross profit (calculated)
- 9,925,000,000 US dollars
- Operating expenses (calculated)
- 7,346,000,000 US dollars
- Operating Income
- 2,579,000,000 US dollars
- Other income (expense), net (calculated)
- negative 698,000,000 US dollars
- Income from Continuing Operations Before Income Taxes
- 1,881,000,000 US dollars
- Income tax provision
- 203,000,000 US dollars
- Net Income
- 1,678,000,000 US dollars
- Medical
- 11,456,000,000 US dollars
- Life Sciences
- 5,167,000,000 US dollars
- Interventional
- 5,217,000,000 US dollars
- Selling and administrative expense
- 5,278,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- Research and development expense
- 1,265,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- Integration, restructuring and transaction expense
- 408,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- Other operating expense (income), net
- 396,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- Loss from Discontinued Operations, Net of Tax
- 0 US dollars. Reported below-tax contribution to net income.
- Medical costs (calculated)
- 7,316,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Life Sciences costs (calculated)
- 3,526,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Interventional costs (calculated)
- 2,964,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Reconciling items (calculated)
- 5,455,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
45.4%
Gross profit / revenue
Operating margin
11.8%
Operating profit / revenue
Cash conversion
204.4%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
